Evening Edition
November 2, 2026
UPI technical failures rise at top banks as ICICI hits 0.73%
NPCI data shows technical UPI declines at the 20 biggest remitter banks rose to 0.24% in September from 0.18%, with ICICI, SBI and Kotak jumping.
Indian startup funding falls 47.5% to $678 million in October
Indian startups raised about $678 million in October 2026, down 47.5% from September, with no round of $100 million or more, Entrackr's monthly report says.
Sun Pharma gets CDSCO nod for generic oral semaglutide pill
India's drug regulator has cleared Sun Pharma to sell a generic oral semaglutide tablet for type 2 diabetes, joining Torrent and Dr Reddy's in a crowded market.
Sun Pharma Q2 profit falls 36% on Rs 1,269 crore of one-offs
Sun Pharma's September-quarter profit fell 36.4% to Rs 1,988.53 crore as antitrust and Organon deal costs hit, while revenue rose to Rs 16,199 crore.
Update: RBI presses banks to prove cyber compliance and audit partner APIs
The RBI has reportedly told banks to prove their cyber rules are followed, audit APIs shared with NBFCs and fintechs, and plan for AI attacks.
Sensex jumps 1,233 points as oil slips below $100 for a third gain
The Sensex rose 1,233 points to 75,693 and the Nifty 388 points to 23,441 on 2 November as crude fell on US-Iran talk hopes, while mid-caps lagged.
Previous edition: Morning Edition, November 2, 2026
Next edition: Morning Edition, November 3, 2026